Comments Regarding Reauthorization of the Over-the-Counter Monograph Drug User Fee Program Share page: Docket Number: FDA-2023-N-3575-0001 Download Document Issues: OTC Medicines Monograph Reform User Fees Related Posts Regulation of OTC Medicines Press Releases and Statements CHPA Congratulates Dr. Doug Bierer as First Recipient of the William Cooley Regulatory & Scientific Affairs Career Achievement Award Sep 18, 2024 Press Releases and Statements Health In Hand Foundation Announces 2024 U.S. Self-Care Marketing Awards Finalists Sep 9, 2024